Security key
92840H400
Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share (VTGN)
CUSIP: 92840H400
Q4 2023 13F Holders as of 31 Dec 2023
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 41,041,331
- Total 13F shares
- 14,910,095
- Share change
- +9,870,368
- Total reported value
- $76,226,105
- Put/Call ratio
- 19%
- Price per share
- $5.14
- Number of holders
- 45
- Value change
- +$50,694,989
- Number of buys
- 34
- Number of sells
- 14
Report period
Q4 2023
Institutions
45
Top holders
10
VTGN full security history
Newer quarter: Q1 2024
Previous quarter: Q3 2023
Vistagen Therapeutics, Inc. SEC filings
Vistagen Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92840H400
Recent filing periods:
Top shareholders of VTGN - Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Commodore Capital LP |
13F
3/4/5
|
Company · 10%+ Owner |
3.8%
|
1,575,000
|
$8,253,000 | — | 30 Sep 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.62%
|
253,715
|
$1,329,467 | — | 30 Sep 2023 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.56%
|
229,100
|
$1,200,485 | — | 30 Sep 2023 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.34%
|
138,500
|
$725,740 | — | 30 Sep 2023 | |
| BML Capital Management, LLC |
13F
|
Company |
0.24%
|
100,000
|
$524,000 | — | 30 Sep 2023 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.24%
|
100,000
|
$524,000 | — | 30 Sep 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.21%
|
88,046
|
$461,361 | — | 30 Sep 2023 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
0.21%
|
85,173
|
$446,307 | — | 30 Sep 2023 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.18%
|
75,305
|
$394,598 | — | 30 Sep 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.18%
|
73,164
|
$383,507 | — | 30 Sep 2023 | |
| MYDA Advisors LLC |
13F
|
Company |
0.12%
|
50,000
|
$262,000 | — | 30 Sep 2023 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.11%
|
46,895
|
$245,730 | — | 30 Sep 2023 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.11%
|
46,782
|
$245,000 | — | 30 Sep 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.06%
|
25,464
|
$133,431 | — | 30 Sep 2023 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.05%
|
20,200
|
$105,848 | — | 30 Sep 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.05%
|
19,355
|
$101,420 | — | 30 Sep 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.04%
|
16,870
|
$88,399 | — | 30 Sep 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.04%
|
14,524
|
$76,106 | — | 30 Sep 2023 | |
| RAYMOND JAMES & ASSOCIATES |
13F
|
Company |
0.02%
|
10,000
|
$52,400 | — | 30 Sep 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.02%
|
8,552
|
$44,812 | — | 30 Sep 2023 | |
| GPS Wealth Strategies Group, LLC |
13F
|
Company |
0.02%
|
8,441
|
$44,231 | — | 30 Sep 2023 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.01%
|
4,813
|
$25,219 | — | 30 Sep 2023 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
2,860
|
$15,000 | — | 30 Sep 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
2,560
|
$13,414 | — | 30 Sep 2023 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.01%
|
2,464
|
$12,000 | — | 30 Sep 2023 | |
| CWM, LLC |
13F
|
Company |
0.01%
|
2,449
|
$13,000 | — | 30 Sep 2023 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,498
|
$7,849 | — | 30 Sep 2023 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0%
|
1,192
|
$6,246 | — | 30 Sep 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
633
|
$3,317 | — | 30 Sep 2023 | |
| EverSource Wealth Advisors, LLC |
13F
|
Company |
0%
|
88
|
$461 | — | 30 Sep 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
68
|
$356 | — | 30 Sep 2023 | |
| TORONTO DOMINION BANK |
13F
|
Company |
0%
|
46
|
$241 | — | 30 Sep 2023 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
41
|
$214 | — | 30 Sep 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
16
|
$84 | — | 30 Sep 2023 | |
| Venrock Healthcare Capital Partners II, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
20,637,286
|
$35,434,220 | — | 12 Jul 2022 | |
| H. Ralph Snodgrass |
3/4/5
|
PRES./CHIEF SCIENTIFIC OFFICER |
—
class O/S missing
|
98,859
|
$169,741 | — | 31 Dec 2021 | |
| Mark Alan Smith |
3/4/5
|
CHIEF MEDICAL OFFICER |
—
class O/S missing
|
19,915
|
$34,194 | — | 30 Jun 2022 | |
| Jerrold Duane Dotson |
3/4/5
|
VP, CFO |
—
class O/S missing
|
3,671
|
$6,303 | — | 30 Jun 2023 |
Institutional Holders of Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share (VTGN) as of Q4 2023
As of 31 Dec 2023,
Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share (VTGN) was held by
45 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,910,095 shares.
The largest 10 holders included
BVF INC/IL, GREAT POINT PARTNERS LLC, VANGUARD GROUP INC, Nantahala Capital Management, LLC, StemPoint Capital LP, COMMODORE CAPITAL LP, SPHERA FUNDS MANAGEMENT LTD., CITADEL ADVISORS LLC, ARMISTICE CAPITAL, LLC, and BlackRock Inc..
This page lists
45
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
34
Q4 2023 holders
45
Holder diff
11
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 Value $ | Q4 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.